Aurobindo Pharma's Lannett Acquisition has officially entered a new phase with the successful completion of its USD 250 million buyout of US-based Lannett Company.
The Union Ministry of Health and Family Welfare has announced a single platform for all medicine-related information, which creates a space that users can easily access for domestic generic medicines through the respective generic name and brand name
Aurobindo Pharma's API Plant Clears FDA Review With Minor Findings as the company received only two observations from the US Food and Drug Administration (USFDA) following an inspection of one of its API plant facilities.
.jpg)
The Imported Drug Shelf Life Rule could soon see a major change in India. The Central government has proposed scrapping the existing 60 percent residual shelf life requirement for imported medicines and replacing it with a simpler 12-month rule.
A packaging loophole allegedly helped counterfeit medicines enter global markets using genuine-looking pharmaceutical packaging.
Patients with rare cancer mutations in India now have access to a globally approved treatment option. Tanstrive, a targeted cancer therapy from Eli Lilly, has been launched in the country for patients with RET-altered tumors.
A new Roche treatment combination has moved a step closer to the market after the US Food and Drug Administration (FDA) accepted the company’s supplemental Biologics License Application (sBLA).
Aurobindo Pharma has moved a step closer to completing its USD 250 million acquisition of Lannett Company after receiving approval from the US Federal Trade Commission (FTC).
The Centre's latest Dengue Preparedness Review comes at a crucial time as the monsoon season approaches and the risk of mosquito-borne diseases begins to rise across the country.
Specialty drugs are becoming the next big growth driver for Indian pharmaceutical companies as the industry looks beyond traditional generic medicines.
, CDSCO.jpg)